FDA Approved: SIGNIFOR LAR — Original Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

The FDA granted original approval for Signifor LAR (pasireotide) from Recordati Rare Diseases, Inc. for the treatment of adults with Cushing's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• SIGNIFOR LAR (PASIREOTIDE)

Snippet

ORIG AP for SIGNIFOR LAR (PASIREOTIDE)